Sign up to save your podcasts
Or
Share E55: Anifrolumab for SLE (TULIP 1&2)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E55: Anifrolumab for SLE (TULIP 1&2)
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
View all episodes
By Michael Putman
4.9
113113 ratings
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
498 Listeners
This Week in Cardiology
878 Listeners
Rheumnow Podcast
131 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Healio Rheuminations
121 Listeners
Annals On Call Podcast
191 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
ACR on Air
67 Listeners
Run the List
247 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
Rheumatology For The Royal College
183 Listeners
RheumMadness Rheumatology Podcast
11 Listeners
ACR Journals On Air
18 Listeners
Talking Rheumatology Spotlight
6 Listeners